Nelum is a clinical-stage biopharmaceutical company developing best-in-class patented molecules with a focus on unmet clinical needs. At Nelum Pharma, we are focused on leveraging our expertise to target fibrosis and various forms of cancer. Our innovative approach and research drive our pursuit of impactful therapies for these challenging conditions.